195 related articles for article (PubMed ID: 23738610)
1. Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats.
Hampe CS; Petrosini L; De Bartolo P; Caporali P; Cutuli D; Laricchiuta D; Foti F; Radtke JR; Vidova V; Honnorat J; Manto M
Orphanet J Rare Dis; 2013 Jun; 8():82. PubMed ID: 23738610
[TBL] [Abstract][Full Text] [Related]
2. Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia.
Manto MU; Hampe CS; Rogemond V; Honnorat J
Orphanet J Rare Dis; 2011 Feb; 6():3. PubMed ID: 21294897
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias.
Mitoma H; Manto M; Hampe CS
J Immunol Res; 2017; 2017():2913297. PubMed ID: 28386570
[TBL] [Abstract][Full Text] [Related]
4. GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.
Liimatainen S; Honnorat J; Pittock SJ; McKeon A; Manto M; Radtke JR; ; Hampe CS
Orphanet J Rare Dis; 2018 Apr; 13(1):55. PubMed ID: 29636076
[TBL] [Abstract][Full Text] [Related]
5. Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats.
Hansen N; Grünewald B; Weishaupt A; Colaço MN; Toyka KV; Sommer C; Geis C
Exp Neurol; 2013 Jan; 239():202-9. PubMed ID: 23099416
[TBL] [Abstract][Full Text] [Related]
6. Reduced display of conformational epitopes in the N-terminal truncated GAD65 isoform: relevance for people with stiff person syndrome or DQ8/8-positive Type 1 diabetes mellitus.
Hampe CS; Radtke JR; Wester A; Carlsson A; Cedervall E; Jönsson B; Ivarsson SA; Elding Larsson H; Larsson K; Lindberg B; Neiderud J; Rolandsson O; Lernmark Å
Diabet Med; 2019 Nov; 36(11):1375-1383. PubMed ID: 30264481
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies directed against glutamate decarboxylase interfere with glucose-stimulated insulin secretion in dispersed rat islets.
Kamat V; Radtke JR; Hu Q; Wang W; Sweet IR; Hampe CS
Int J Exp Pathol; 2022 Aug; 103(4):140-148. PubMed ID: 35246889
[TBL] [Abstract][Full Text] [Related]
8. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients.
Raju R; Foote J; Banga JP; Hall TR; Padoa CJ; Dalakas MC; Ortqvist E; Hampe CS
J Immunol; 2005 Dec; 175(11):7755-62. PubMed ID: 16301686
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs.
Padoa CJ; Banga JP; Madec AM; Ziegler M; Schlosser M; Ortqvist E; Kockum I; Palmer J; Rolandsson O; Binder KA; Foote J; Luo D; Hampe CS
Diabetes; 2003 Nov; 52(11):2689-95. PubMed ID: 14578287
[TBL] [Abstract][Full Text] [Related]
10. Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse.
Wang X; Zhang A; Liu Y; Chen S; Feng Z; Shang W; Maziarz M; Radtke J; Hampe CS
PLoS One; 2012; 7(2):e32515. PubMed ID: 22384267
[TBL] [Abstract][Full Text] [Related]
11. Masked and overt autoantibodies specific to the DPD epitope of 65-kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved β-cell functional reserve in ketosis-prone diabetes.
Oak S; Gaur LK; Radtke J; Patel R; Iyer D; Ram N; Gaba R; Balasubramanyam A; Hampe CS
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1040-4. PubMed ID: 24601691
[TBL] [Abstract][Full Text] [Related]
12. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.
Reijonen H; Daniels TL; Lernmark A; Nepom GT
Diabetes; 2000 Oct; 49(10):1621-6. PubMed ID: 11016444
[TBL] [Abstract][Full Text] [Related]
13. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11.
Fenalti G; Hampe CS; O'connor K; Banga JP; Mackay IR; Rowley MJ; El-Kabbani O
Mol Immunol; 2007 Feb; 44(6):1178-89. PubMed ID: 16930708
[TBL] [Abstract][Full Text] [Related]
15. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
[TBL] [Abstract][Full Text] [Related]
16. The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes.
Oak S; Gilliam LK; Landin-Olsson M; Törn C; Kockum I; Pennington CR; Rowley MJ; Christie MR; Banga JP; Hampe CS
Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5471-6. PubMed ID: 18367670
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.
Hampe CS; Hall TR; Agren A; Rolandsson O
Clin Exp Immunol; 2007 Apr; 148(1):72-8. PubMed ID: 17286757
[TBL] [Abstract][Full Text] [Related]
19. High titers of autoantibodies to glutamate decarboxylase in type 1 diabetes patients: epitope analysis and inhibition of enzyme activity.
Hampe CS; Maitland ME; Gilliam LK; Phan TH; Sweet IR; Radtke JR; Bota V; Ransom BR; Hirsch IB
Endocr Pract; 2013; 19(4):663-8. PubMed ID: 23512385
[TBL] [Abstract][Full Text] [Related]
20. Multiplicity of the antibody response to GAD65 in Type I diabetes.
Gilliam LK; Binder KA; Banga JP; Madec AM; Ortqvist E; Kockum I; Luo D; Hampe CS
Clin Exp Immunol; 2004 Nov; 138(2):337-41. PubMed ID: 15498046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
